A. Screen all male patients older than 55 years old and all female patients older than 65 B. Screen all patients who present with symptoms of rapid and/or irregular heart rate C. Screen only patients presenting with symptoms consistent with a stroke D. Screen only patients who have access to a continuous heart rhythm monitor E. Unsure

A. A 75-year-old female patient with a history of osteoarthritis B. A 55-year-old male patient with history of hypertension, type 2 diabetes, and myocardial infarction C. A 78-year-old male patient with history of heart failure, end-stage renal disease, and gout D. A 60-year-old male patient with a history of rheumatoid arthritis, chronic obstructive culinary disease (COPD), and psoriasis E. Unsure

A. She has a HAS-BLED score of 1 indicating low risk of bleeding and no barrier to anticoagulant use B. She has a HAS-BLED score of 2 indicating high risk of bleeding but anticoagulants can still be used if the stroke risk outweighs the bleeding risk C. She has a HAS-BLED score of 3 indicating high risk of bleeding but anticoagulants can still be used if bleeding risk factors are addressed D. She has a HAS-BLED score of 3 indicating high risk of bleeding and anticoagulants are contraindicated since none of the risk factors are modifiable E. Unsure

A. Warfarin dose adjusted to target INR 2-3 B. Apixaban 2.5 mg twice daily C. Dabigatran 75 mg twice daily D. Edoxaban 60 mg daily E. Unsure

A. Cost of medication B. Complexity of dosing schedule C. Fear of bleeding D. Prefers to use “natural” therapies instead E. Unsure